ONESOURCE SPECIALTY PHARMA
Back to Balance Sheet
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹1,114 Cr | ₹631 Cr | ₹865 Cr | ₹809 Cr |
What is the latest Total Current Liabilities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,114 Cr |
| Mar2024 | ₹631 Cr |
| Mar2023 | ₹865 Cr |
| Mar2022 | ₹809 Cr |
How is Total Current Liabilities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,114 Cr | 76.59 | |
| Mar2024 | ₹631 Cr | -27.12 | |
| Mar2023 | ₹865 Cr | 6.99 | |
| Mar2022 | ₹809 Cr | - | |
Compare Total Current Liabilities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹19,337.6 Cr | 5.5% | -10.2% | -17.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 5.5% |
-10.2% |
-17.1% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses